October 9, 2019
AbbVie Japan President James Feliciano in Interview with Jiho on Oct. 8 AbbVie’s foray into the Japanese oncology market is drawing near. Its first cancer drug Venclexta (venetoclax) is slated for listing in November, while what is expected to be...read more